UnitedHealth Group Incorporated (NYSE:UNH) is BlackBarn Capital Partners LP's 2nd Largest Position

BlackBarn Capital Partners LP boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 133.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,000 shares of the healthcare conglomerate's stock after acquiring an additional 34,300 shares during the period. UnitedHealth Group comprises approximately 1.7% of BlackBarn Capital Partners LP's portfolio, making the stock its 2nd largest position. BlackBarn Capital Partners LP's holdings in UnitedHealth Group were worth $30,352,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Western Pacific Wealth Management LP lifted its stake in UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after acquiring an additional 19 shares during the last quarter. MCF Advisors LLC boosted its holdings in UnitedHealth Group by 0.8% in the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after purchasing an additional 20 shares in the last quarter. Axiom Financial Strategies LLC raised its holdings in UnitedHealth Group by 3.6% during the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock valued at $291,000 after buying an additional 20 shares in the last quarter. Richwood Investment Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after acquiring an additional 20 shares during the last quarter. Finally, Prentice Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock worth $1,278,000 after buying an additional 21 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Up 0.3 %

Shares of UNH traded up $1.07 during trading hours on Wednesday, hitting $428.25. The company had a trading volume of 8,338,869 shares, compared to its average volume of 4,439,721. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $391.73 billion, a P/E ratio of 27.63, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $417.12 and a 52-week high of $630.73. The stock's 50 day moving average price is $506.92 and its 200 day moving average price is $537.23.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the business posted $6.91 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 35.18%.

Analyst Ratings Changes

Several research firms recently weighed in on UNH. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Mizuho raised their price target on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Truist Financial reduced their price target on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research report on Monday. Finally, KeyCorp dropped their price target on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research report on Monday. Three analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $604.67.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.